Follow
Prof. Gheyath K. Nasrallah
Prof. Gheyath K. Nasrallah
Professor of Biomedical Science, College of Health Sciences, QU health, Qatar University
Verified email at qu.edu.qa - Homepage
Title
Cited by
Cited by
Year
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B. 1.1. 7 and B. 1.351 Variants
LJ Abu-Raddad, H Chemaitelly, AA Butt
New England Journal of Medicine 385 (2), 187-189, 2021
11232021
Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar
H Chemaitelly, P Tang, MR Hasan, S AlMukdad, HM Yassine, ...
New England Journal of Medicine 385 (24), e83, 2021
9132021
Potential adverse effects of resveratrol: A literature review
A Shaito, AM Posadino, N Younes, H Hasan, S Halabi, D Alhababi, ...
International journal of molecular sciences 21 (6), 2084, 2020
5212020
Effects of previous infection and vaccination on symptomatic omicron infections
HN Altarawneh, H Chemaitelly, HH Ayoub, P Tang, MR Hasan, ...
New England Journal of Medicine 387 (1), 21-34, 2022
5092022
Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms
MK Smatti, FS Cyprian, GK Nasrallah, AA Al Thani, RO Almishal, ...
Viruses 11 (8), 762, 2019
5032019
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
P Tang, MR Hasan, H Chemaitelly, HM Yassine, FM Benslimane, ...
Nature medicine 27 (12), 2136-2143, 2021
4762021
Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2
N Younes, DW Al-Sadeq, H Al-Jighefee, S Younes, O Al-Jamal, HI Daas, ...
Viruses 12 (6), 582, 2020
4512020
Protection against the Omicron variant from previous SARS-CoV-2 infection
HN Altarawneh, H Chemaitelly, MR Hasan, HH Ayoub, S Qassim, ...
New England Journal of Medicine 386 (13), 1288-1290, 2022
4352022
mRNA-1273 COVID-19 vaccine effectiveness against the B. 1.1. 7 and B. 1.351 variants and severe COVID-19 disease in Qatar
H Chemaitelly, HM Yassine, FM Benslimane, HA Al Khatib, P Tang, ...
Nature medicine 27 (9), 1614-1621, 2021
4222021
Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar
LJ Abu-Raddad, H Chemaitelly, HH Ayoub, S AlMukdad, HM Yassine, ...
New England Journal of Medicine 386 (19), 1804-1816, 2022
3932022
Epstein–Barr virus epidemiology, serology, and genetic variability of LMP-1 oncogene among healthy population: an update
MK Smatti, DW Al-Sadeq, NH Ali, G Pintus, H Abou-Saleh, GK Nasrallah
Frontiers in oncology 8, 211, 2018
3752018
Herbal medicine for cardiovascular diseases: efficacy, mechanisms, and safety
A Shaito, DTB Thuan, HT Phu, THD Nguyen, H Hasan, S Halabi, ...
Frontiers in pharmacology 11, 422, 2020
3462020
Synthesis, bioapplications, and toxicity evaluation of chitosan-based nanoparticles
BR Rizeq, NN Younes, K Rasool, GK Nasrallah
International journal of molecular sciences 20 (22), 5776, 2019
2712019
Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms
H Slika, H Mansour, N Wehbe, SA Nasser, R Iratni, G Nasrallah, A Shaito, ...
Biomedicine & Pharmacotherapy 146, 112442, 2022
2642022
Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
THG Phan, P Paliogiannis, GK Nasrallah, R Giordo, AH Eid, AG Fois, ...
Cellular and Molecular Life Sciences 78, 2031-2057, 2021
2622021
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA. 1 and BA. 2 subvariants in Qatar
H Chemaitelly, HH Ayoub, S AlMukdad, P Coyle, P Tang, HM Yassine, ...
Nature communications 13 (1), 3082, 2022
2402022
Pseudomonas Aeruginosa: Arsenal of Resistance Mechanisms, Decades of Changing Resistance Profiles, and Future Antimicrobial Therapies
ME El Zowalaty, AA Al Thani, TJ Webster, AE El Zowalaty, HP Schweizer, ...
Future Microbiology 10 (10), 1683-1706, 2015
2102015
Anti-cancer properties and mechanisms of action of thymoquinone, the major active ingredient of Nigella sativa
AF Majdalawieh, MW Fayyad, GK Nasrallah
Critical reviews in food science and nutrition 57 (18), 3911-3928, 2017
2012017
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy
LJ Abu-Raddad, H Chemaitelly, P Coyle, JA Malek, AA Ahmed, ...
EClinicalMedicine 35, 2021
1902021
Severity of SARS-CoV-2 reinfections as compared with primary infections
LJ Abu-Raddad, H Chemaitelly, R Bertollini
New England Journal of Medicine 385 (26), 2487-2489, 2021
1892021
The system can't perform the operation now. Try again later.
Articles 1–20